fda compounding semaglutide warning letters news Compounded "semaglutide" is not FDA-approved Drug compounders sue FDA over

Retatrutide is a new type of injectable weight loss drug known as a triple hormone receptor agonist

Some potential patients are rightly concerned about safety, while others question the effectiveness of GLP-1 injections for their long-term weight loss goals

Yes, families may bring a wrongful death claim if the evidence shows that complications from a GLP-1 drug played a role in a loved ones passing

Knowing what to avoid helps you achieve better results

We monitor your labs, muscle mass, and organ function to ensure you are losing fat, not muscle, and doing so safely

It is typically mild, described as a queasy feeling rather than active vomiting, and peaks 12 to 24 hours after injection